Article PDF
Avoid common mistakes on your manuscript.
References
Dulin WE, Wyse BM, Kalamazoo MS (1969) Studies on the ability of compounds to block the diabetogenic activity of streptozotocin. Diabetes 18:459–466
Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarui S (1982) Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. Diabetes 31:749–753
Yonemura Y, Takishima T, Miwa K, Miyazadi I, Yamamota H, Okamoto H (1984) Amelioration of diabetes mellitus in partially depancreatized rats by poly (ADP-ribose) synthetase inhibitors. Diabetes 33: 401–404.
Sandler S, Andersson A, Korsgren O et al. (1986) Tissue culture of human fetal pancreas. Effects of nicotinamide on insulin production and formation of islet like cell clusters. Diabetes 38 [Suppl 1]: 168–171
Mandrup-Poulsen T, Helqvist S, Wogensen LD et al. (1990) Cytokines and free radicals as effector molecules in the destruction of the pancreatic β-cells. Curr Top Microbiol Immunol 164: 169–193
Rankin PW, Jacobsen EL, Benjamin RC, Moss J, Jacobsen MK (1989) Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. J Biol Chem 264: 4312–4317
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pociot, F., Reimers, J.I. & Andersen, H.U. Nicotinamide — biological actions and therapeutic potential in diabetes prevention. Diabetologia 36, 574–576 (1993). https://doi.org/10.1007/BF02743277
Issue Date:
DOI: https://doi.org/10.1007/BF02743277